06:34 AM EST, 03/03/2025 (MT Newswires) -- Apogee Therapeutics ( APGE ) reported a 2024 net loss Monday of $182.1 million, widening from a loss of $84 million a year earlier.

Analysts polled by FactSet expected a loss of $177.9 million.

At the end of the year, cash, cash equivalents and marketable securities were $731.1 million. The company said it expects its existing cash, cash equivalents and marketable securities to allow it to fund its operating expenses into Q1 2028.

Apogee shares were up 1.5% in recent premarket activity.